Biomedical Innovation at McGill

There is increasing pressure on PIs to translate research dollars into concrete results that will have an impact on therapeutics and health care delivery.  However, the infrastructure and knowledge necessary to move discoveries from the lab into the clinic or marketplace is fractured and in general, not well organized.  The Faculty of Medicine at McGill recognizes this and as a result, has asked Prof. Phil Barker to head up a new unit termed the McGill Centre for Biomedical Innovation (MCBI).   The goal of this new unit is to enhance the PI’s ability to take their basic research along development routes that will have a societal impact.

Please join us on May 10th (at 10:30 am in the Charles Martin Theatre (Room 504) in the McIntyre Building) for an informative session on various programs and resources available to PIs to aid in their path from discovery to commercialization.  Presentations will be given by Dr. Natalie Dakers, CEO, The Centre for Drug Research and Development (CDRD); Dr. Diane Gosselin, Vice President of Research and Business Development of CQDM;  and Dr. Elizabeth Douville, Vice President, Genechem.

A light lunch will be served afterwards and each of the speakers will be available to chat.  In addition there is the opportunity to meet with members of the CDRD on May 10th and 11th.

For further information or to RSVP, please contact Natasha Laliberté at 398-5569 or by e-mail at Natasha.laliberte [at] mcgill.ca.